S2-E30.2 - The Global Liver Institute US NASH Action Plan - Common, Reliable Diagnostics Are Critical
Send us a text Global Liver Institute Director of Global Policy Andrew Scott, Madrigal Pharmaceuticals Co-Founder and CMO Becky Taub, and Central Virginia VA Health Care System Chief of Hepatology and Gastroenterology Dr. Michael Fuchs discuss GLI's US NASH Action Plan and steps different stakeholders can take to support the Plan. In this conversation, the group discusses the need for common, reliable non-invasive diagnostic tests and education for providers on which tests they should rely on...
12 Juni 202114min
S2-E30.1 - The Global Liver Institute US NASH Action Plan - Overview And What Education Must Achieve
Send us a text Global Liver Institute Director of Global Policy Andrew Scott, Madrigal Pharmaceuticals Co-Founder and CMO Becky Taub, and Central Virginia VA Health Care System Chief of Hepatology and Gastroenterology Dr. Michael Fuchs discuss GLI's US NASH Action Plan and steps different stakeholders can take to support the Plan. In this conversation, Andrew discusses the genesis of the US NASH Action Plan and the group begins to discuss education and awareness opportunities. Andrew Scott wa...
12 Juni 202116min
S2-E30 - The Global Liver institute US NASH Action Plan - What It Is and How We All Can Help Support it
Send us a text Global Liver Institute Director of Global Policy Andrew Scott walks a diverse set of stakeholders through the US NASH Action Plan, with special focus on education, awareness and clarity in diagnosis and treatment. In addition to Andrew, Becky Taub, Madrigal Pharmaceuticals co-founder, Director, CMO and President of Research & Development and Dr.Michael Fuchs, Acting Chief of the Division of Gastroenterology and Hepatology and the Central Virginia VA Health Care System, join...
10 Juni 20211h
S2-E29.3 - Previewing Digital ILC 2021 -- Part 1 -- What might emerge?
Send us a text EASL Scientific Committee member Luca Valenti joins the Surfers to "crystal ball" potential key outcomes from Digital ILC 2021. The four panelists each predict one likely outcome from Digital ILC 2021. Interestingly, none of them focus specifically on clinical trials, but instead on a broader range of issues around understanding the metabolic underpinnings of NASH and determining treatment plans and strategy for today, before the new generation of medications arrives.
6 Juni 202112min
S2-E29.2 - Previewing Digital ILC 2021 -- Part 1 -- Interests and Issues
Send us a text EASL Scientific Committee member Luca Valenti joins the Surfers to discuss some of the issues that will be discussed at Digital ILC 2021. After Luca and Stephen Harrison discuss what they consider highlights of this month's Digital ILC meeting, Louise Campbell and Roger Green join them to discuss some of the key issues they anticipate being address at EASL's signature annual event.
5 Juni 202112min
S2-E29.1 - Previewing Digital ILC 2021 -- Part 1 -- Meeting Overview
Send us a text Stephen Harrison and EASL Scientific Committee member Luca Valenti Preview Highlights of the Digital ILC 2021. Luca and Stephen discuss what each of them consider highlights of this month's Digital ILC meeting, focusing not only on presentation and poster topics but also a new meeting platform with improved connectivity. This brief discussion will help you get in the right frame of mind for planning your participation at EASL's signature annual event.
5 Juni 202112min
S2-E29 - Previewing Digital ILC 2021 -- Part 1
Send us a text EASL Scientific Organizing Committee member Prof. Luca Valenti joins the Surfers to discuss some of the major NAFLD-related topics we will learn more about at Digital ILC 2021. This episode begins with the announcement that Surfing the NASH Tsunami is an official Media Partner for Digital ILC 2021! The rest of the episode is devoted to discussing how the meeting came together, some of the major learning opportunities and areas for the meeting, and exciting details on EASL's imp...
3 Juni 202142min
S2-E27.2 - A Deeper Look At International NASH Day 2021 -- Activities, Future Plans, And Global Liver Institute Growth
Send us a text Global Liver Institute President and CEO Donna Cryer joins the Surfers to discuss International NASH Day 2021. This conversation takes a deeper look at NASH Day and also Global Liver Institute's growth and future plans. The 4th annual International NASH Day is a major global institution, with endorsements from WHO, EASL, AASLD, at least 14 medical societies, and organizations in at least 26 countries, and more than 100,000 people tuning in at some point during the day. In this ...
29 Maj 202120min
